Does palivizumab prophylaxe reduce hospitalization due to RSV in young children with hemodynamically significant congenital heart disease?

H. B. Grotenhuis, K. Fijnvandraat, C. C. de Kruiff

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)10-11
JournalPediatric clinics Amsterdam
Volume20
Issue number4
Publication statusPublished - 2009

Cite this